Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ejendomsselskabet Hinnerup Sundhedshus ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   2.9% 2.3% 2.1% 1.5% 2.1% 2.2% 9.6% 9.4%   Credit score (0-100)   59 65 66 75 66 66 26 26   Credit rating   BBB BBB A A A BBB BB BB   Credit limit (kDKK)   0.0 0.1 0.3 12.3 0.3 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   224 492 532 549 560 517 0.0 0.0   EBITDA   189 492 532 549 560 517 0.0 0.0   EBIT   77.4 343 384 400 411 368 0.0 0.0   Pre-tax profit (PTP)   -171.8 239.5 288.0 983.1 226.3 184.9 0.0 0.0   Net earnings   -171.8 172.4 190.5 732.3 140.8 110.6 0.0 0.0   Pre-tax profit without non-rec. items   -172 239 288 983 226 185 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   8,576 8,427 8,279 8,130 7,981 7,832 0.0 0.0   Shareholders equity total   2,784 2,956 3,147 3,779 3,840 3,950 3,810 3,810   Interest-bearing liabilities   5,655 5,354 4,732 3,823 3,651 3,475 0.0 0.0   Balance sheet total (assets)   8,996 8,704 8,336 8,306 8,010 7,874 3,810 3,810   Net Debt   5,237 5,077 4,677 3,680 3,651 3,474 -3,810 -3,810     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   224 492 532 549 560 517 0.0 0.0   Gross profit growth   0.0% 119.9% 8.2% 3.2% 1.9% -7.7% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,996 8,704 8,336 8,306 8,010 7,874 3,810 3,810   Balance sheet change%   -43.5% -3.2% -4.2% -0.4% -3.6% -1.7% -51.6% 0.0%   Added value   188.7 492.2 532.4 549.2 559.7 516.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,882 -298 -298 -298 -298 -298 -7,832 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.6% 69.8% 72.0% 72.9% 73.4% 71.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.6% 3.9% 4.5% 12.6% 5.0% 4.6% 0.0% 0.0%   ROI %   0.8% 4.1% 4.7% 13.6% 5.3% 4.7% 0.0% 0.0%   ROE %   -6.0% 6.0% 6.2% 21.1% 3.7% 2.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   30.9% 34.0% 37.8% 45.5% 47.9% 50.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,775.2% 1,031.4% 878.5% 670.2% 652.3% 672.4% 0.0% 0.0%   Gearing %   203.1% 181.1% 150.4% 101.2% 95.1% 88.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.6% 1.9% 1.9% 1.6% 4.9% 5.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.0   Current Ratio   0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.0   Cash and cash equivalent   417.9 276.6 54.9 143.0 0.0 1.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -811.9 -741.5 -654.8 -751.2 -328.0 -243.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 560 517 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 560 517 0 0   EBIT / employee   0 0 0 0 411 368 0 0   Net earnings / employee   0 0 0 0 141 111 0 0